Literature DB >> 1521437

Acute hypoxemic respiratory failure in infants and children: clinical and pathologic characteristics.

W DeBruin1, D A Notterman, M Magid, T Godwin, S Johnston.   

Abstract

OBJECTIVE: To examine the clinical and pathologic features of acute hypoxemic respiratory failure in children.
DESIGN: Retrospective review of medical records and pathologic material during a 44-month period.
SETTING: Multidisciplinary pediatric ICU. PATIENTS AND METHODS: With the assistance of a computerized database, the medical records of 2,254 pediatric ICU admissions were evaluated to identify children with respiratory failure. Children with acute hypoxemic respiratory failure who met the following definition were selected for inclusion: a) PaO2 less than 75 torr (less than 10.0 kPa) with an FIO2 of greater than 0.5; b) diffuse bilateral infiltrates on chest radiograph; and c) exclusion of cardiogenic pulmonary edema clinically or by pulmonary artery catheterization. Patients were excluded if they did not receive tracheal intubation and assisted ventilation. The medical records were reviewed for demographic, clinical, and physiologic information. Pathologic findings from autopsy or lung biopsy were also reviewed. Patients were placed in one of six groups based on their underlying disorder. In addition, the presence of neutropenia, septic shock, or a history of bone marrow transplantation was noted as a coexisting condition. MAIN
RESULTS: A total of 100 acute hypoxemic respiratory failure patients were identified (4.4% of all 2,254 pediatric ICU admissions; 50 male, 50 female). Mean age was 6.0 +/- 5.4 (SD) yrs (range 1 month to 18 yrs). The overall mortality rate was 72%. The mortality rate was not affected by the underlying disorder, but it was higher in the presence of septic shock (80% vs. 58%; odds ratio 2.8), neutropenia (88% vs. 64%; odds ratio 4.0), and bone marrow transplantation (95% vs. 66%; odds ratio 10.4). When multivariate regression analysis was performed using all coexisting conditions, human immunodeficiency virus status, and patient gender, only a history of bone marrow transplantation and gender appeared to affect outcome. Oxygenation ratio (PaO2/FIO2), alveolar-arterial oxygen tension difference, duration of exposure to high levels of oxygen, and airway pressure measurements indicated more severe derangement of pulmonary function in those patients who died. Cardiac function was similar in survivors and nonsurvivors. Respiratory failure occurred in 32 children with severe neutropenia (mean absolute neutrophil count 55 +/- 101 cells/mm3), including 16 children with an absolute neutrophil count of 0. Pulmonary tissue from 37 children was studied. Diffuse alveolar damage was observed in 24%; morphologic evidence of infectious pneumonitis was encountered in an additional 41%.
CONCLUSIONS: Children with acute hypoxemic respiratory failure represent a heterogeneous subset of patients. In our group of patients, infectious pneumonitis was more commonly encountered than diffuse alveolar damage. The mortality rate of children with acute hypoxemic respiratory failure has not improved since 1980.

Entities:  

Mesh:

Year:  1992        PMID: 1521437     DOI: 10.1097/00003246-199209000-00008

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  14 in total

1.  The prognosis of oncologic patients in the pediatric intensive care unit.

Authors:  A van Veen; A Karstens; A C van der Hoek; D Tibboel; K Hählen; E van der Voort
Journal:  Intensive Care Med       Date:  1996-03       Impact factor: 17.440

2.  Early Right Ventricular Systolic Dysfunction and Pulmonary Hypertension Are Associated With Worse Outcomes in Pediatric Acute Respiratory Distress Syndrome.

Authors:  Adam S Himebauch; Nadir Yehya; Yan Wang; Thomas Conlon; Todd J Kilbaugh; Francis X McGowan; Laura Mercer-Rosa
Journal:  Crit Care Med       Date:  2018-11       Impact factor: 7.598

Review 3.  Treatment of newborn infants with inhaled nitric oxide.

Authors:  R H Mupanemunda; A D Edwards
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1995-03       Impact factor: 5.747

4.  Randomised trial of three doses of inhaled nitric oxide in acute respiratory distress syndrome.

Authors:  S F Tang; M C Sherwood; O I Miller
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

5.  Surfactant treatment for acute respiratory distress syndrome.

Authors:  J López-Herce; N de Lucas; A Carrillo; A Bustinza; R Moral
Journal:  Arch Dis Child       Date:  1999-03       Impact factor: 3.791

6.  Respiratory syncytial virus triggered adult respiratory distress syndrome in infants: a report of two cases.

Authors:  D C Bachmann; J Pfenninger
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

Review 7.  Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; Gloria S Pryhuber; Patricia R Chess; Bruce A Davidson; Paul R Knight; Robert H Notter
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 8.  Surfactant for pediatric acute lung injury.

Authors:  Douglas F Willson; Patricia R Chess; Robert H Notter
Journal:  Pediatr Clin North Am       Date:  2008-06       Impact factor: 3.278

Review 9.  Partial liquid ventilation for the prevention of mortality and morbidity in paediatric acute lung injury and acute respiratory distress syndrome.

Authors:  Alka Kaushal; Conor G McDonnell; Mark W Davies
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

10.  Effect of body position on ventilation distribution during PEEP titration in a porcine model of acute lung injury using advanced respiratory monitoring and electrical impedance tomography.

Authors:  Klaus Pfurtscheller; Stefan Ring; Elisabeth Beran; Erich Sorantin; Joachim Zobel; David Ganster; Alexander Avian; Gerfried Zobel
Journal:  Intensive Care Med Exp       Date:  2015-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.